Abstract:Importance: Women who had a hypertensive disorder of pregnancy (HDP) have a well-documented risk of chronic hypertension within a few years of delivery, but management of postpartum hypertension among these women remains inconsistent. Objective: To assess the incidence of initiation of antihypertensive medication use in the first 2 years after delivery by HDP status and antenatal antihypertensive medication use. Design, setting, and participants: This Danish register-based cohort study used data from women with at least 1 pregnancy lasting 20 or more gestational weeks (only the first pregnancy in the period was considered) who delivered from January 1, 1995, to December 31, 2018. Statistical analysis was conducted from October 2022 to September 2023. Exposure: Hypertensive disorders of pregnancy. Main outcomes and measures: Cumulative incidences and hazard ratios of initiating antihypertensive medication use within 2 years post partum (5 postpartum time intervals) by HDP status and antenatal medication use. Results: The cohort included 784 782 women, of whom 36 900 (4.7% [95% CI, 4.7%-4.8%]) had an HDP (HDP: median age at delivery, 29.1 years [IQR, 26.1-32.7 years]; no HDP: median age at delivery, 29.0 years [IQR, 25.9-32.3 years]). The 2-year cumulative incidence of initiating postpartum antihypertensive treatment ranged from 1.8% (95% CI, 1.8%-1.8%) among women who had not had HDPs to 44.1% (95% CI, 40.0%-48.2%) among women with severe preeclampsia who required antihypertensive medication during pregnancy. Most women who required postpartum antihypertensive medication after an HDP initiated use within 3 months of delivery (severe preeclampsia, 86.6% [95% CI, 84.6%-89.4%]; preeclampsia, 75.3% [95% CI, 73.8%-76.2%]; and gestational hypertension, 75.1% [95% CI, 72.9%-77.1%]). However, 13.4% (95% CI, 11.9%-14.1%) of women with severe preeclampsia, 24.7.% (95% CI, 24.0%-26.0%) of women with preeclampsia, 24.9% (95% CI, 22.5%-27.5%) of women with gestational hypertension, and 76.7% (95% CI, 76.3%-77.1%) of those without an HDP first filled a prescription for antihypertensive medication more than 3 months after delivery. Women with gestational hypertension had the highest rate of initiating medication after more than 1 year post partum, with 11.6% (95% CI, 10.0%-13.2%) starting treatment after this period. Among women who filled a prescription in the first 3 months post partum, up to 55.9% (95% CI, 46.2%-66.1%) required further prescriptions more than 3 months post partum, depending on HDP status and antenatal medication use. Conclusions and relevance: In this cohort study of postpartum women, the incidence of initiation of postnatal antihypertensive medication use varied by HDP status, HDP severity, and antenatal antihypertensive medication use. Up to 24.9% of women initiated antihypertensive medication use more than 3 months after an HDP, with up to 11.6% initiating treatment after 1 year. Routine postpartum blood pressure monitoring might prevent diagnostic delays in initiation of antihypertensive medication use and improve cardiovascular disease prevention among women.

Risks of Hypertensive Disorders in the Second Pregnancy

Does Developing Interpregnancy Hypertension Affect the Recurrence Risk of Preeclampsia? A Population-Based Cohort Study

Association of Hypertensive Disorders of Pregnancy with Infant Growth in the First 36 Months of Life

[Risk Factors of Recurrent Preeclampsia and Its Relation to Maternal and Offspring Outcome].

Adverse Outcomes during Postpartum Readmissions after Deliveries Complicated by Hypertensive Disorders of Pregnancy

Trends in Hypertensive Disorders of Pregnancy in the United States From 1989 to 2020

Hypertension arising after 20 weeks of gestation: gestational hypertension or masked chronic hypertension?

Ri sk factors fo recurrent preeclampsia and i ts relation ot mta ernal and fo fspring outcome

The Risk of Persistent Hypertension and Chronic Kidney Disease in Early- and Late-Onset Preeclampsia: A Report From Developing Country

Calculation of the resonant ionization of helium.

Increased Adverse Pregnancy Outcomes Associated with Stage 1 Hypertension in a Low-Risk Cohort: Evidence from 47 874 Cases.

Chronic hypertension diagnosed before or during pregnancy and its effects on pregnancy outcomes

Human Chorionic Gonadotropin, Fetal Sex and Risk of Hypertensive Disorders of Pregnancy: A Nested Case-Control Study

Maternal and Perinatal Prognosis of Pregnancy with Chronic Hypertension and Analysis of Associated Factors

Factors Associated with Early Readmission for Postpartum Hypertension

Hypertensive Disorders of Pregnancy and the Cardiovascular System: Causes, Consequences, Therapy, and Prevention

Radiographic evidence of craniofacial and dental abnormalities in the X-linked hypophosphatemic mouse.

Pregnancy Outcomes in Women Who Developed Elevated Blood Pressure and Stage I Hypertension after 20 Weeks Gestation

Patterns of Antihypertensive Medication Use in the First 2 Years Post Partum

Postpartum Course of Gestational Hypertension and Preeclampsia

Comparing the severity of second preeclampsia with first preeclampsia: a multicenter retrospective longitudinal cohort study